Skip to content

Systematic review, 2023

What hormonal treatments have been tested for PMDD, menstrual migraine, and catamenial epilepsy?

Hormonal treatments have been tested 56 times for premenstrual mood disorder, 21 times for menstrual migraine, and 8 times for catamenial epilepsy. Combined oral contraceptives were a frequent focus.

Strong study design Reproductive-aged females with natural menstrual cycles and premenstrual mood disorder, menstrual migraine, or catamenial epilepsy

What they did

Scoping review of 85 human studies published between 1950 and 2021. Included studies of reproductive-aged females with natural menstrual cycles who received hormonal treatments and were measured across at least two menstrual cycle phases.

What they found

Exogenous hormone manipulations were tested for premenstrual mood disorder (56 trials), menstrual migraine (21 trials), and catamenial epilepsy (8 trials). Combined oral contraceptives containing drospirenone were specifically noted.

What it means for you

These three menstrual cycle-related brain disorders have overlapping hormonal mechanisms and could benefit from shared research approaches, but researchers in each field have historically worked independently. The main limitation is that the provided abstract is incomplete.

85

Studies reviewed

56

Trials for premenstrual mood disorder

21

Trials for menstrual migraine

About the study

Original title
A scoping review of hormonal clinical trials in menstrual cycle-related brain disorders: Studies in premenstrual mood disorder, menstrual migraine, and catamenial epilepsy
Authors
Barone JC, Butler MP, Ross A et al.
Journal
Frontiers in neuroendocrinology
Year
2023
Study design
Systematic review
What was tested
Exogenous hormone manipulation (various types, including combined oral contraceptives)
Open access
Yes

Topics